Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Mor, David Kenley Published: Journal of Endocrinology and Metabolism, Volume 4, Number 3, June 2014, pages 6477 DOI: 10.14740/jem213w URL: Two in vitro genotoxicity assays were conducted
By inhibiting NNMT, 5-Amino-1MQ has been investigated for its potential to increase intracellular NAD+ levels and modulate lipid metabolism in preclinical settings
It was investigated as a candidate obesity therapeutic but did not meet its primary endpoints in clinical trials, and no marketing approval followed
No, needles and syringes should never be reused
Better Sleep : B12 helps regulate your sleep-wake cycle, contributing to more restful and rejuvenating sleep
US$ 20.88
US$ 29.39
US$ 29.44
US$ 28.76
US$ 22.36
US$ 24.91
US$ 27.98